# Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

Study · id `cardio:ct-nct03251963` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03251963](<https://clinicaltrials.gov/study/NCT03251963>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03251963

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 131 participants.

## Technical summary

Registry record NCT03251963. Non-randomized; no masking; primary purpose other. Start 2017-09-15 (actual); primary completion 2019-03-27 (actual). Results posted on 2020-07-08.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose other
- Phase: Phase 2
- Enrolled: 131 participants (enrolled count; ClinicalTrials.gov record NCT03251963, source copy `cardio:ctgov-nct03251963-2020-07-08`, retrieved 2026-10-31)
- Started: 2017-09-15 (actual) (ClinicalTrials.gov record NCT03251963, source copy `cardio:ctgov-nct03251963-2020-07-08`, retrieved 2026-10-31)
- Primary completion: 2019-03-27 (actual) (ClinicalTrials.gov record NCT03251963, source copy `cardio:ctgov-nct03251963-2020-07-08`, retrieved 2026-10-31)
- Completion: 2019-07-27 (actual) (ClinicalTrials.gov record NCT03251963, source copy `cardio:ctgov-nct03251963-2020-07-08`, retrieved 2026-10-31)
- Results first posted: 2020-07-08 (ClinicalTrials.gov record NCT03251963, source copy `cardio:ctgov-nct03251963-2020-07-08`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT03251963, source copy `cardio:ctgov-nct03251963-2020-07-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03251963-2020-07-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients
- Condition: Venous Thromboembolism
- Condition: Deep Venous Thrombosis
- Condition: Surgery
- Intervention (Drug): Fixed Dose Enoxaparin
- Intervention (Drug): Variable Dose Enoxaparin
- Lead sponsor: University of Utah
- Lead sponsor class: OTHER
- Collaborator: University of Michigan
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry lists this organization as the lead sponsor: University of Utah (`cardio:org-university-of-utah`)
- Registry lists this organization as a collaborator: University of Michigan (`cardio:org-university-of-michigan`)

## Provenance

Content hash: 4f12ba466bb31ea65c72eef3d2da75274da142eb8068c21fcdeb5fa453749e90
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
